SAM
NTUS

Shell Asset Management’s Natus Medical Inc NTUS Stock Holding History

Shell Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,507
Closed -$312K – 1415
2022
Q2 		$312K Buy
9,507
+16
+0.2% +$506 0.01% 962
2022
Q1 		$249K Sell
9,491
-1,405
-13% -$34.3K 0.01% 1112
2021
Q4 		$259K Buy
10,896
+53
+0.5% +$1.31K 0.01% 1140
2021
Q3 		$272K Sell
10,843
-470
-4% -$12K 0.01% 1113
2021
Q2 		$294K Buy
11,313
+9,440
+504% +$257K 0.01% 1122
2021
Q1 		$48K Hold
1,873
– – ﹤0.01% 1406
2020
Q4 		$38K Hold
1,873
– – ﹤0.01% 1409
2020
Q3 		$32K Hold
1,873
– – ﹤0.01% 1331
2020
Q2 		$41K Buy
+1,873
New +$42.9K ﹤0.01% 1283

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Shell Asset Management's NTUS Position: Q3 2022 in Review

Shell Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 9,507 shares — an estimated $312K sold.

Shell Asset Management first reported a position in NTUS in Q2 2020 and held it in 9 quarters. The position peaked at $312K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Shell Asset Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Shell Asset Management sold 9,507 Natus Medical Inc shares in Q3 2022, an estimated $312K.
  • Shell Asset Management first reported a position in Natus Medical Inc in Q2 2020 and held it in 9 quarters.
  • Shell Asset Management's Natus Medical Inc position peaked at $312K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Shell Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.